SCHEMBL32675944

SCHEMBL32675944

CCCCCCC=C(CCCC)CCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.50
TSHR P16473 2/20 0.44
TERT O14746 3/20 0.43
PTPN1 P18031 3/20 0.43
PPARG P37231 3/20 0.43
PPARD Q03181 3/20 0.43
PPARA Q07869 3/20 0.43
TOP1 P11387 3/20 0.43
CYP1A2 P05177 2/20 0.43
MAPT P10636 2/20 0.43
CYP2C19 P33261 2/20 0.43
BLM P54132 2/20 0.43
HSD17B10 Q99714 2/20 0.43
FABP4 P15090 2/20 0.43
FAAH O00519 2/20 0.43
KMT2A Q03164 2/20 0.43
GMNN O75496 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11055246 0.95 EP300 (0.50) EP300TERTPTPN1PPARGPPARD
SCHEMBL11055241 0.95 EP300 (0.50) EP300TERTPTPN1PPARGPPARD
SCHEMBL11789217 0.95 EP300 (0.50) EP300TERTPTPN1PPARGPPARD
SCHEMBL11789494 0.95 EP300 (0.50) EP300TERTPTPN1PPARGPPARD
SCHEMBL11790163 0.95 EP300 (0.50) EP300TERTPTPN1PPARGPPARD
SCHEMBL27603791 0.95 EP300 (0.50) EP300TERTPTPN1PPARGPPARD
SCHEMBL27563971 0.93 EP300 (0.43) EP300TSHRTERTPTPN1PPARG
SCHEMBL641493 0.92 EP300 (0.46) EP300TERTPTPN1PPARGPPARD
SCHEMBL11773059 0.91 EP300 (0.44) EP300TSHRPPARGPPARACYP1A2
SCHEMBL11773056 0.91 EP300 (0.44) EP300TSHRPPARGPPARACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026043730-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-02-26 WO claimed
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2026-02-19 US claimed
US-12618016-B2 Methods for producing aviation fuels CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-05-05 US disclosed
WO-2026043730-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2026-02-26 WO disclosed
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2026-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12618016-B2 Methods for producing aviation fuels CYP4F8, CYP8B1, CYP2E1 EP300 2553/4885TSHR 4270/4885TERT 1468/4885
US-20260049256-A1 METHODS FOR PRODUCING AVIATION FUELS CYP4F8, CPT1A, CBR1 EP300 3493/4885TSHR 4431/4885TERT 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.